![]() |
||||
![]() |
HOME CAREER CONTACT US ![]() |
|||
![]() |
||||
![]() |
||||
|
BCIRG presented the following study results at the SABCS 2006:
BCIRG 006: 2nd Interim Analysis
Presented by Dr. Dennis Slamon, December 14 2006
CIRG Sanofi-Aventis joint Press Releases:
BCIRG 103: Poster Session I: Prognosis and Response Prediction: Predictive Factors I Expression of EGFR ligands betacellulin and tenascin C are associated with molecular response following gefitinib treatment in women with primary breast cancer presented at the SABCS by Dr Richard Finn from Geffen School of Medicine at UCLA, Los Angeles, CA
|
|||
![]() |